TRAZIMERA Poudre pour solution Canadá - francês - Health Canada

trazimera poudre pour solution

pfizer canada ulc - trastuzumab - poudre pour solution - 440mg - trastuzumab 440mg - antineoplastic agents

TRAZIMERA Poudre pour solution Canadá - francês - Health Canada

trazimera poudre pour solution

pfizer canada ulc - trastuzumab - poudre pour solution - 150mg - trastuzumab 150mg - antineoplastic agents

HERCEPTIN Poudre pour solution Canadá - francês - Health Canada

herceptin poudre pour solution

hoffmann-la roche limited - trastuzumab - poudre pour solution - 440mg - trastuzumab 440mg - antineoplastic agents

ONTRUZANT Poudre pour solution Canadá - francês - Health Canada

ontruzant poudre pour solution

samsung bioepis co., ltd - trastuzumab - poudre pour solution - 150mg - trastuzumab 150mg

ONTRUZANT Poudre pour solution Canadá - francês - Health Canada

ontruzant poudre pour solution

samsung bioepis co., ltd - trastuzumab - poudre pour solution - 440mg - trastuzumab 440mg

GAZYVA Solution Canadá - francês - Health Canada

gazyva solution

hoffmann-la roche limited - obinutuzumab - solution - 25mg - obinutuzumab 25mg - antineoplastic agents

LEMTRADA Solution Canadá - francês - Health Canada

lemtrada solution

sanofi genzyme, a division of sanofi-aventis canada inc - alemtuzumab - solution - 12mg - alemtuzumab 12mg - antineoplastic agents

Entyvio subkutan 108 mg Injektionslösung  in einem Fertigpen Suíça - francês - Swissmedic (Swiss Agency for Therapeutic Products)

entyvio subkutan 108 mg injektionslösung in einem fertigpen

takeda pharma ag - vedolizumabum - injektionslösung in einem fertigpen - vedolizumabum 108 mg, acidum citricum monohydricum, natrii citras dihydricus corresp. natrium 1.11 mg, histidinum, histidini hydrochloridum monohydricum, arginini hydrochloridum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 0.68 ml. - la colite ulcérative, morbus crohn - biotechnologika

Entyvio subkutan 108 mg Injektionslösung  in einer Fertigspritze Suíça - francês - Swissmedic (Swiss Agency for Therapeutic Products)

entyvio subkutan 108 mg injektionslösung in einer fertigspritze

takeda pharma ag - vedolizumabum - injektionslösung in einer fertigspritze - vedolizumabum 108 mg, acidum citricum monohydricum, natrii citras dihydricus corresp. natrium 1.11 mg, histidinum, histidini hydrochloridum monohydricum, arginini hydrochloridum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 0.68 ml. - la colite ulcérative, morbus crohn - biotechnologika

Indium DTPA (In-111) injection Curium Solution injectable Suíça - francês - Swissmedic (Swiss Agency for Therapeutic Products)

indium dtpa (in-111) injection curium solution injectable

b.e.imaging.ag - indii(111) de dinatrii pentetas, salicylicium penteticum - solution injectable - indii(111) de dinatrii pentetas 37 mbq, l'acide penteticum 100 µg, de calcium chloridum dihydricum, dinatrii phosphas dodecahydricus, natrii chloridum, aqua ad iniectabilia q. s. pour une solution au lieu de 1 ml. - szintigraphische représentation du liquorraumes - radiopharmazeutika